View by category
What are the 2022-2023 PharmaPendium content statistics?
Last updated on April 24, 2024
The content release includes the following updates:
8 new drugs in PharmaPendium
- Capivasertib
- Efbemalenograstim Alfa
- Fruquintinib
- Nirogacestat Hydrobromide
- Repotrectinib
- Sitagliptin; Metformin Hydrochloride
- Taurolidine; Heparin Sodium
- Vonoprazan Fumarate
FDA Approval Documents:
- 224 new FDA Approval Documents
- 2,920 new pages of FDA Approval Documents
FDA Advisory Committee Documents:
- 176 new FDA Advisory Committee Documents
- 3,964 new pages of FDA Advisory Committee Documents
The new totals for PharmaPendium are:
- 3,136,545 pages of FDA Approval documents (Including FDA Classic Collection)
- 153,389 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,925 drugs with data in PharmaPendium
- 2,471,778 extracted safety data lines
- 2,347,648 extracted PK data lines
- 620,866 extracted ME data lines
- 3,987,017 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 21,438,356 FAERS (post-marketing) reports
- 19,092 documents / 411,698 pages of EMA Approval documents
- 21,797 documents / 825,423 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
The content release includes the following updates:
3 new drugs in PharmaPendium
- Anthrax Vaccine Adsorbed, Adjuvanted
- Prothrombin Complex Concentrate, Human-Lans
- Tislelizumab
FDA Approval Documents:
- 332 new FDA Approval Documents
- 4,939 new pages of FDA Approval Documents
EMA Documents:
- 69 new EMA documents
- 2,755 new pages of EMA Documents
Extracted PK data observations:
- 5,139 new extracted PK data lines
Extracted Safety data observations:
- 4,849 new extracted safety data lines
Metabolizing Enzymes Database:
- 1,600 new ME extracted data lines
Published Toxicity Database:
- 706 new safety records
The new totals for PharmaPendium are:
- 3,133,625 pages of FDA Approval documents (Including FDA Classic Collection)
- 153,165 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,917 drugs with data in PharmaPendium
- 2,471,778 extracted safety data lines
- 2,347,658 extracted PK data lines
- 619,871 extracted ME data lines
- 3,987,017 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 21,438,357 FAERS (post-marketing) reports
- 19,092 documents / 411,698 pages of EMA Approval documents
- 21,621 documents / 821,459 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
The content release includes the following updates:
9 new drugs in PharmaPendium
- Clindamycin Phosphate; Adapalene; Benzoyl Peroxide
- Etrasimod
- Gepirone Hydrochloride
- Nedosiran Sodium
- Sitagliptin
- Technetium Tc-99m Labeled Carbon
- Toripalimab
- Vamorolone
- Zilucoplan
FDA Approval Documents:
- 347 new FDA Approval Documents
- 6,007 new pages of FDA Approval Documents
FAERS:
- 405,174 new FAERS reports (2023_Q3)
The new totals for PharmaPendium are:
- 3,128,686 pages of FDA Approval documents (Including FDA Classic Collection)
- 152,833 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,914 drugs with data in PharmaPendium
- 2,466,223 extracted safety data lines
- 2,342,519 extracted PK data lines
- 618,271 extracted ME data lines
- 3,987,017 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 21,438,357 FAERS (post-marketing) reports
- 19,023 documents / 408,943 pages of EMA Approval documents
- 21,621 documents / 821,459 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
1 new drug in PharmaPendium
- Gefapixant Citrate
FDA Approval Documents:
- 401 new FDA Approval Documents
- 5,439 new pages of FDA Approval Documents
EMA Documents:
- 101 new EMA documents
- 620 updated EMA documents
- 3,151 new pages of EMA Documents
Extracted PK data observations:
- 5,433 new extracted PK data lines
Extracted Safety data observations:
- 10,345 new extracted safety data lines
Metabolizing Enzymes Database:
- 4,153 new ME extracted data lines
Published Toxicity Database:
- 498 new safety records
Efficacy Database:
- 28,128 new extracted data lines
The new totals for PharmaPendium are:
- 3,122,679 pages of FDA Approval documents (Including FDA Classic Collection)
- 152,486 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,905 drugs with data in PharmaPendium
- 2,466,223 extracted safety data lines
- 2,342,519 extracted PK data lines
- 618,266 extracted ME data lines
- 3,987,017 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 21,033,183 FAERS (post-marketing) reports
- 19,023 documents / 408,943 pages of EMA Approval documents
- 21,621 documents / 821,459 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
3 new drugs in PharmaPendium
- Elranatamab
- Momelotinib Dihydrochloride
- Motixafortide Acetate
FDA Approval Documents:
- 534 new FDA Approval Documents
- 6,245 new pages of FDA Approval Documents
FDA Advisory Committee Documents:
- 85 new FDA Advisory Committee Documents
- 5,000 new pages of FDA Advisory Committee Documents
The new totals for PharmaPendium are:
- 3,117,240 pages of FDA Approval documents (Including FDA Classic Collection)
- 152,085 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,904 drugs with data in PharmaPendium
- 2,455,380 extracted safety data lines
- 2,337,086 extracted PK data lines
- 614,113 extracted ME data lines
- 3,958,889 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 21,033,183 FAERS (post-marketing) reports
- 18,922 documents / 405,792 pages of EMA Approval documents
- 21,621 documents / 821,459 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
FDA Approval Documents:
- 327 new FDA Approval Documents
- 4,376 new pages of FDA Approval Documents
EMA Documents:
- 51 new EMA documents
- 2,632 new pages of EMA Documents
Extracted PK data observations:
- 4,503 new extracted PK data lines
Extracted Safety data observations:
- 4,787 new extracted safety data lines
Metabolizing Enzymes Database:
- 1,007 new ME extracted data lines
Published Toxicity Database:
- 472 new safety records
The new totals for PharmaPendium are:
- 3,110,995 pages of FDA Approval documents (Including FDA Classic Collection)
- 151,551 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,901 drugs with data in PharmaPendium
- 2,455,513 extracted safety data lines
- 2,337,086 extracted PK data lines
- 614,113 extracted ME data lines
- 3,958,889 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 21,033,183 FAERS (post-marketing) reports
- 18,922 documents / 405,792 pages of EMA Approval documents
- 21,536 documents / 816,459 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
The content release includes the following updates:
7 new drugs in PharmaPendium
- Avacincaptad Pegol Sodium
- Delandistrogene Moxeparvovec
- Donislecel
- Palovarotene
- Pozelimab
- Talquetamab
- Zuranolone
FDA Approval Documents:
- 206 new FDA Approval Documents
- 2,827 new pages of FDA Approval Documents
The new totals for PharmaPendium are:
- 3,106,619 pages of FDA Approval documents (Including FDA Classic Collection)
- 151,224 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,901 drugs with data in PharmaPendium
- 2,450,254 extracted safety data lines
- 2,332,583 extracted PK data lines
- 613,106 extracted ME data lines
- 3,958,889 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 21,033,183 FAERS (post-marketing) reports
- 18,871 documents / 403,160 pages of EMA Approval documents
- 21,536 documents / 816,459 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
The content release includes the following updates:
1 new drug in PharmaPendium
- Sitagliptin Fumarate; Metformin Hydrochloride
FDA Approval Documents:
- 391 new FDA Approval Documents
- 5,780 new pages of FDA Approval Documents
EMA Documents:
- 112 new EMA documents
- 632 updated EMA documents
- 4,213 new pages of EMA Documents
Extracted PK data observations:
- 6,354 new extracted PK data lines
Extracted Safety data observations:
- 10,992 new extracted safety data lines
Metabolizing Enzymes Database:
- 4,863 new ME extracted data lines
Published Toxicity Database:
- 605 new safety records
Efficacy Database:
- 47,288 new extracted data lines
The new totals for PharmaPendium are:
- 3,103,792 pages of FDA Approval documents (Including FDA Classic Collection)
- 151,018 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,894 drugs with data in PharmaPendium
- 2,450,254 extracted safety data lines
- 2,332,583 extracted PK data lines
- 613,135 extracted ME data lines
- 3,958,889 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 21,033,183 FAERS (post-marketing) reports
- 18,871 documents / 403,160 pages of EMA Approval documents
- 21,536 documents / 816,459 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
Last updated on August 23, 2023
The content release includes the following updates:
4 new drugs in PharmaPendium
- Beremagene Geperpavec
- Cantharidin
- Lotilaner
- Respiratory Syncytial Virus Vaccine
FDA Approval Documents:
- 515 new FDA Approval Documents
- 5,799 new pages of FDA Approval Documents
FDA Advisory Committee Documents:
- 184 new FDA Advisory Committee Documents
- 4,661 new pages of FDA Advisory Committee Documents
FAERS:
- 416,330 new FAERS reports (2023_Q2)
The new totals for PharmaPendium are:
- 3,098,012 pages of FDA Approval documents (Including FDA Classic Collection)
- 150,627 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,893 drugs with data in PharmaPendium
- 2,438,657 extracted safety data lines
- 2,326,229 extracted PK data lines
- 608,272 extracted ME data lines
- 3,911,601 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 21,033,176 FAERS (post-marketing) reports
- 18,759 documents / 398,947 pages of EMA Approval documents
- 21,536 documents / 816,459 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
The content release includes the following updates:
1 new drug in PharmaPendium
- Mirikizumab
FDA Approval Documents:
- 472 new FDA Approval Documents
- 6,090 new pages of FDA Approval Documents
EMA Documents:
- 87 new EMA documents
- 4,039 new pages of EMA Documents
Extracted PK data observations:
- 2,569 new extracted PK data lines
Extracted Safety data observations:
- 4,287 new extracted safety data lines
Metabolizing Enzymes Database:
- 1,627 new ME extracted data lines
Published Toxicity Database:
- 717 new safety records
The new totals for PharmaPendium are:
- 3,092,213 pages of FDA Approval documents (Including FDA Classic Collection)
- 150,112 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,889 drugs with data in PharmaPendium
- 2,438,657 extracted safety data lines
- 2,326,229 extracted PK data lines
- 608,272 extracted ME data lines
- 3,911,601 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 20,616,846 FAERS (post-marketing) reports
- 18,759 documents / 398,947 pages of EMA Approval documents
- 21,352 documents / 811,798 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
The content release includes the following updates:
6 new drugs in PharmaPendium
- Efgartigimod Alfa; Hyaluronidase
- Glofitamab
- Niraparib Tosylate Monohydrate; Abiraterone Acetate
- Polyethylene Glycol 3350; Sodium, Magnesium Sulfate; Potassium, Sodium Chloride
- Ritlecitinib Tosylate
- Rozanolixizumab
FDA Approval Documents:
- 339 new FDA Approval Documents
- 4,948 new pages of FDA Approval Documents
The new totals for PharmaPendium are:
- 3,086,123 pages of FDA Approval documents (Including FDA Classic Collection)
- 149,640 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,888 drugs with data in PharmaPendium
- 2,433,653 extracted safety data lines
- 2,323,660 extracted PK data lines
- 606,945 extracted ME data lines
- 3,911,601 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 20,616,846 FAERS (post-marketing) reports
- 18,672 documents / 394,908 pages of EMA Approval documents
- 21,352 documents / 811,798 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
The content release includes the following updates:
2 new drugs in PharmaPendium
- Cipaglucosidase Alfa
- Vadadustat
FDA Approval Documents:
- 463 new FDA Approval Documents
- 6,367 new pages of FDA Approval Documents
EMA Documents:
- 106 new EMA documents
- 715 updated EMA documents
- 4,177 new pages of EMA Documents
Extracted PK data observations:
- 6,261 new extracted PK data lines
Extracted Safety data observations:
- 9,114 new extracted safety data lines
Metabolizing Enzymes Database:
- 5,797 new ME extracted data lines
Published Toxicity Database:
- 530 new safety records
Efficacy Database:
- 27,094 new extracted data lines
The new totals for PharmaPendium are:
- 3,081,175 pages of FDA Approval documents (Including FDA Classic Collection)
- 149,301 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,882 drugs with data in PharmaPendium
- 2,433,653 extracted safety data lines
- 2,323,713 extracted PK data lines
- 606,659 extracted ME data lines
- 3,911,601 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 20,616,627 FAERS (post-marketing) reports
- 18,672 documents / 394,908 pages of EMA Approval documents
- 21,352 documents / 811,798 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
The content release includes the following updates:
9 new drugs in PharmaPendium
- Epcoritamab
- Fecal Microbiota Spores, Live
- Fezolinetant
- Flotufolastat F-18
- Omidubicel
- Pegunigalsidase Alfa
- Perfluorohexyloctane
- Sulbactam; Durlobactam
- Tropicamide; Phenylephrine Hydrochloride
FDA Approval Documents:
- 410 new FDA Approval Documents
- 5,192 new pages of FDA Approval Documents
FDA Advisory Committee Documents:
- 255 new FDA Advisory Committee Documents
- 4,770 new pages of FDA Advisory Committee Documents
The new totals for PharmaPendium are:
- 3,074,808 pages of FDA Approval documents (Including FDA Classic Collection)
- 148,838 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,880 drugs with data in PharmaPendium
- 2,424,009 extracted safety data lines
- 2,317,452 extracted PK data lines
- 600,862 extracted ME data lines
- 3,884,507 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 20,616,625 FAERS (post-marketing) reports
- 18,566 documents / 390,731 pages of EMA Approval documents
- 21,352 documents / 811,798 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
The content release includes the following updates:
FDA Approval Documents:
- 153 new FDA Approval Documents
- 2,320 new pages of FDA Approval Documents
EMA Documents:
- 68 new EMA documents
- 2,575 new pages of EMA Documents
Extracted PK data observations:
- 3,856 new extracted PK data lines
Extracted Safety data observations:
- 4,114 new extracted safety data lines
Metabolizing Enzymes Database:
- 1,909 new ME extracted data lines
Published Toxicity Database:
- 410 new safety records
The new totals for PharmaPendium are:
- 3,069,616 pages of FDA Approval documents (Including FDA Classic Collection)
- 148,428 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,871 drugs with data in PharmaPendium
- 2,424,009 extracted safety data lines
- 2,317,452 extracted PK data lines
- 600,862 extracted ME data lines
- 3,884,507 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 20,616,625 FAERS (post-marketing) reports
- 18,566 documents / 390,731 pages of EMA Approval documents
- 21,097 documents / 807,028 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
The content release includes the following updates:
2 new drugs in PharmaPendium
- Respiratory Syncytial Virus Vaccine, Adjuvanted
- Tofersen
FDA Approval Documents:
- 327 new FDA Approval Documents
- 4,827 new pages of FDA Approval Documents
FAERS:
- 426,722 new FAERS reports
The new totals for PharmaPendium are:
- 3,067,296 pages of FDA Approval documents (Including FDA Classic Collection)
- 148,275 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,871 drugs with data in PharmaPendium
- 2,419,485 extracted safety data lines
- 2,313,596 extracted PK data lines
- 598,953 extracted ME data lines
- 3,884,507 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 20,616,625 FAERS (post-marketing) reports
- 18,498 documents / 388,156 pages of EMA Approval documents
- 21,097 documents / 807,028 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
The content release includes the following updates:
1 new drug in PharmaPendium
- COVID-19 Vaccine (Hipra)
FDA Approval Documents:
- 283 new FDA Approval Documents
- 4,037 new pages of FDA Approval Documents
- 106 new EMA documents
- 548 updated EMA documents
- 3,364 new pages of EMA Documents
Extracted PK data observations:
- 7,071 new extracted PK data lines
Extracted Safety data observations:
- 8,539 new extracted safety data lines
Metabolizing Enzymes Database:
- 4,731 new ME extracted data lines
Published Toxicity Database:
- 547 new safety records
Efficacy Database:
- 23,879 new extracted data lines
The new totals for PharmaPendium are:
- 3,062,469 pages of FDA Approval documents (Including FDA Classic Collection)
- 147,948 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,869 drugs with data in PharmaPendium
- 2,419,485 extracted safety data lines
- 2,313,596 extracted PK data lines
- 598,957 extracted ME data lines
- 3,884,507 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 20,189,903 FAERS (post-marketing) reports
- 18,498 documents / 388,156 pages of EMA Approval documents
- 21,097 documents / 807,028 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
The content release includes the following updates:
8 new drugs in PharmaPendium
- Antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl
- Leniolisib Phosphate
- Nadofaragene Firadenovec
- Omaveloxolone
- Retifanlimab
- Rezafungin
- Trofinetide
- Zavegepant Hydrochloride
FDA Approval Documents:
- 303 new FDA Approval Documents
- 3,744 new pages of FDA Approval Documents
FDA Advisory Committee Documents:
- 114 new FDA Advisory Committee Documents
- 3,190 new pages of FDA Advisory Committee Documents
The new totals for PharmaPendium are:
- 3,058,432 pages of FDA Approval documents (Including FDA Classic Collection)
- 147,665 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,868 drugs with data in PharmaPendium
- 2,410,399 extracted safety data lines
- 2,306,525 extracted PK data lines
- 594,226 extracted ME data lines
- 3,860,628 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 20,189,903 FAERS (post-marketing) reports
- 18,392 documents / 384,792 pages of EMA Approval documents
- 21,097 documents / 807,028 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
The content release includes the following updates:
FDA Approval Documents:
- 393 new FDA Approval Documents
- 4,966 new pages of FDA Approval Documents
EMA Documents:
- 63 new EMA documents
- 3,443 new pages of EMA Documents
Extracted PK data observations:
- 4,256 new extracted PK data lines
Extracted Safety data observations:
- 4,490 new extracted safety data lines
Metabolizing Enzymes Database:
- 3,726 new ME extracted data lines
Published Toxicity Database:
- 600 new safety records
The new totals for PharmaPendium are:
- 3,054,688 pages of FDA Approval documents (Including FDA Classic Collection)
- 147,362 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,860 drugs with data in PharmaPendium
- 2,410,399 extracted safety data lines
- 2,306,525 extracted PK data lines
- 594,226 extracted ME data lines
- 3,860,628 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 20,189,903 FAERS (post-marketing) reports
- 18,392 documents / 384,792 pages of EMA Approval documents
- 20,983 documents / 803,838 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
The content release includes the following updates:
6 new drugs in PharmaPendium
- Daprodustat
- Deutetrabenzine
- Neostigmine Methylsulfate; Glycopyrrolate
- Phenobarbital Sodium
- Pirtobrutinib
- Sparsentan
FDA Approval Documents:
- 413 new FDA Approval Documents
- 5,759 new pages of FDA Approval Documents
The new totals for PharmaPendium are:
- 3,049,722 pages of FDA Approval documents (Including FDA Classic Collection)
- 146,969 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,860 drugs with data in PharmaPendium
- 2,405,309 extracted safety data lines
- 2,302,269 extracted PK data lines
- 590,500 extracted ME data lines
- 3,860,628 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 20,189,903 FAERS (post-marketing) reports
- 18,329 documents / 381,349 pages of EMA Approval documents
- 20,983 documents / 803,838 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
The content release includes the following updates:
1 new drug in PharmaPendium
- Tabelecleucel
FDA Approval Documents:
- 327 new FDA Approval Documents
- 4,947 new pages of FDA Approval Documents
EMA Documents:
- 79 new EMA documents
- 689 updated EMA documents
- 1,858 new pages of EMA Documents
Extracted PK data observations:
- 4,699 new extracted PK data lines
Extracted Safety data observations:
- 13,102 new extracted safety data lines
Metabolizing Enzymes Database:
- 5,051 new ME extracted data lines
Published Toxicity Database:
- 385 new safety records
Efficacy Database:
- 46,863 new extracted data lines
The new totals for PharmaPendium are:
- 3,043,963 pages of FDA Approval documents (Including FDA Classic Collection)
- 146,556 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,854 drugs with data in PharmaPendium
- 2,405,309 extracted safety data lines
- 2,302,269 extracted PK data lines
- 590,520 extracted ME data lines
- 3,860,628 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 20,189,868 FAERS (post-marketing) reports
- 18,329 documents / 381,349 pages of EMA Approval documents
- 20,983 documents / 803,838 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
The content release includes the following updates:
7 new drugs in PharmaPendium
- Albuterol; Budesonide
- Anacaulase
- Bexagliflozin
- Elacestrant
- Lecanemab
- Ublituximab
- Xenon Xe-129 Hyperpolarized
FDA Approval Documents:
- 223 new FDA Approval Documents
- 3,533 new pages of FDA Approval Documents
FDA Advisory Committee Documents:
- 90 new FDA Advisory Committee Documents
- 3,178 new pages of FDA Advisory Committee Documents
FAERS:
- 484,816 new FAERS reports (2022_Q4)
The new totals for PharmaPendium are:
- 3,039,016 pages of FDA Approval documents (Including FDA Classic Collection)
- 146,229 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,853 drugs with data in PharmaPendium
- 2,391,822 extracted safety data lines
- 2,297,570 extracted PK data lines
- 585,469 extracted ME data lines
- 3,813,765 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 20,189,868 FAERS (post-marketing) reports
- 18,250 documents / 379,491 pages of EMA Approval documents
- 20,983 documents / 803,838 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
The content release includes the following updates:
FDA Approval Documents:
- 241 new FDA Approval Documents
- 3,582 new pages of FDA Approval Documents
EMA Documents:
- 143 new EMA documents
- 6,849 new pages of EMA Documents
Extracted PK data observations:
- 4,902 new extracted PK data lines
Extracted Safety data observations:
- 4,444 new extracted safety data lines
Metabolizing Enzymes Database:
- 3,182 new ME extracted data lines
Published Toxicity Database:
- 433 new safety records
The new totals for PharmaPendium are:
- 3,035,483 pages of FDA Approval documents (Including FDA Classic Collection)
- 146,006 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,846 drugs with data in PharmaPendium
- 2,391,822 extracted safety data lines
- 2,297,661 extracted PK data lines
- 585,596 extracted ME data lines
- 3,813,765 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 19,705,052 FAERS (post-marketing) reports
- 18,250 documents / 379,491 pages of EMA Approval documents
- 20,893 documents / 800,660 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
The content release includes the following updates:
4 new drugs in PharmaPendium
- Adagrasib
- Etranacogene Dezaparvovec
- Fecal Microbiota, Live
- Olutasidenib
FDA Approval Documents:
- 416 new FDA Approval Documents
- 4,496 new pages of FDA Approval Documents
The new totals for PharmaPendium are:
- 3,031,901 pages of FDA Approval documents (Including FDA Classic Collection)
- 145,765 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,846 drugs with data in PharmaPendium
- 2,386,945 extracted safety data lines
- 2,292,759 extracted PK data lines
- 582,414 extracted ME data lines
- 3,813,765 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 19,705,052 FAERS (post-marketing) reports
- 18,107 documents / 372,642 pages of EMA Approval documents
- 20,893 documents / 800,660 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
The content release includes the following updates:
2 new drugs in PharmaPendium
- COVID-19 Vaccine (Vidprevtyn Beta)
- Nirsevimab
FDA Approval Documents:
- 568 new FDA Approval Documents
- 6,671 new pages of FDA Approval Documents
EMA Documents:
- 101 new EMA documents
- 629 updated EMA documents
- 3,290 new pages of EMA Documents
Extracted PK data observations:
- 5,898 new extracted PK data lines
Extracted Safety data observations:
- 16,452 new extracted safety data lines
Metabolizing Enzymes Database:
- 8,272 new ME extracted data lines
Published Toxicity Database:
- 524 new safety records
Efficacy Database:
- 35,670 new extracted data lines
The new totals for PharmaPendium are:
- 3,027,405 pages of FDA Approval documents (Including FDA Classic Collection)
- 145,349 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,842 drugs with data in PharmaPendium
- 2,386,945 extracted safety data lines
- 2,292,780 extracted PK data lines
- 582,536 extracted ME data lines
- 3,813,765 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 19,705,052 FAERS (post-marketing) reports
- 18,107 documents / 372,642 pages of EMA Approval documents
- 20,893 documents / 800,660 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
The content release includes the following updates:
2 new drugs in PharmaPendium
- Mirvetuximab Soravtansine
- Teplizumab
FDA Approval Documents:
- 199 new FDA Approval Documents
- 2,994 new pages of FDA Approval Documents
FDA Advisory Committee Documents:
- 143 new FDA Advisory Committee Documents
- 4,398 new pages of FDA Advisory Committee Documents
The new totals for PharmaPendium are:
- 3,020,734 pages of FDA Approval documents (Including FDA Classic Collection)
- 144,781 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,840 drugs with data in PharmaPendium
- 2,369,969 extracted safety data lines
- 2,286,882 extracted PK data lines
- 574,264 extracted ME data lines
- 3,778,095 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 19,705,052 FAERS (post-marketing) reports
- 18,006 documents / 369,352 pages of EMA Approval documents
- 20,893 documents / 800,660 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
The content release includes the following updates:
FDA Approval Documents:
- 213 new FDA Approval Documents
- 2,535 new pages of FDA Approval Documents
EMA Documents:
- 81 new EMA documents
- 2,293 new pages of EMA Documents
Extracted PK data observations:
- 3,497 new extracted PK data lines
Extracted Safety data observations:
- 6,917 new extracted safety data lines
Metabolizing Enzymes Database:
- 1,113 new ME extracted data lines
Published Toxicity Database:
- 503 new safety records
The new totals for PharmaPendium are:
- 3,017,740 pages of FDA Approval documents (Including FDA Classic Collection)
- 144,582 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,838 drugs with data in PharmaPendium
- 2,369,770 extracted safety data lines
- 2,286,518 extracted PK data lines
- 574,264 extracted ME data lines
- 3,776,644 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 19,705,052 FAERS (post-marketing) reports
- 18,006 documents / 369,317 pages of EMA Approval documents
- 20,750 documents / 796,262 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
The content release includes the following updates:
3 new drugs in PharmaPendium
- Futibatinib
- Teclistamab
- Tremelimumab
FDA Approval Documents:
- 295 new FDA Approval Documents
- 4,418 new pages of FDA Approval Documents
FAERS:
- 443,265 new FAERS reports (2022_Q3)
The new totals for PharmaPendium are:
- 3,015,205 pages of FDA Approval documents (Including FDA Classic Collection)
- 144,369 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,838 drugs with data in PharmaPendium
- 2,362,350 extracted safety data lines
- 2,283,021 extracted PK data lines
- 573,151 extracted ME data lines
- 3,776,644 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 19,705,052 FAERS (post-marketing) reports
- 17,925 documents / 367,024 pages of EMA Approval documents
- 20,750 documents / 796,262 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
The content release includes the following updates:
1 new drug in PharmaPendium
- Valoctocogene Roxaparvovec
FDA Approval Documents:
- 480 new FDA Approval Documents
- 8,407 new pages of FDA Approval Documents
EMA Documents:
- 100 new EMA documents
- 768 updated EMA documents
- 3,344 new pages of EMA Documents
Extracted PK data observations:
- 4,966 new extracted PK data lines
Extracted Safety data observations:
- 9,907 new extracted safety data lines
Metabolizing Enzymes Database:
- 7,500 new ME extracted data lines
Published Toxicity Database:
- 265 new safety records
Efficacy Database:
- 27,875 new extracted data lines
The new totals for PharmaPendium are:
- 3,010,787 pages of FDA Approval documents (Including FDA Classic Collection)
- 144,074 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,835 drugs with data in PharmaPendium
- 2,362,350 extracted safety data lines
- 2,283,021 extracted PK data lines
- 573,133 extracted ME data lines
- 3,776,644 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 19,261,787 FAERS (post-marketing) reports
- 17,925 documents / 367,024 pages of EMA Approval documents
- 20,750 documents / 796,262 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
The content release includes the following updates:
6 new drugs in PharmaPendium
- Daxibotulinumtoxina
- Deucravacitinib
- Eflapegrastim
- Gadopiclenol
- Omidenepag Isopropyl
- Sodium Phenylbutyrate; Sodium Taurursodiol
FDA Approval Documents:
- 316 new FDA Approval Documents
- 4,548 new pages of FDA Approval Documents
FDA Advisory Committee Documents:
- 101 new FDA Advisory Committee Documents
- 3,297 new pages of FDA Advisory Committee Documents
The new totals for PharmaPendium are:
- 3,002,380 pages of FDA Approval documents (Including FDA Classic Collection)
- 143,594 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,834 drugs with data in PharmaPendium
- 2,352,178 extracted safety data lines
- 2,278,055 extracted PK data lines
- 565,633 extracted ME data lines
- 3,748,769 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 19,261,787 FAERS (post-marketing) reports
- 17,825 documents / 363,680 pages of EMA Approval documents
- 20,750 documents / 796,262 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
The content release includes the following updates:
3 new drugs in PharmaPendium
- Eladocagene Exuparvovec
- Lenacapavir Sodium
- Sitagliptin Hydrochloride; Metformin Hydrochloride
FDA Approval Documents:
- 228 new FDA Approval Documents
- 2,919 new pages of FDA Approval Documents
EMA Documents:
- 98 new EMA documents
- 2,927 new pages of EMA Documents
Extracted PK data observations:
- 5,348 new extracted PK data lines
Extracted Safety data observations:
- 4,066 new extracted safety data lines
Metabolizing Enzymes Database:
- 2,880 new ME extracted data lines
Published Toxicity Database:
- 784 new safety records
The new totals for PharmaPendium are:
- 2,997,832 pages of FDA Approval documents (Including FDA Classic Collection)
- 143,278 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,828 drugs with data in PharmaPendium
- 2,352,121 extracted safety data lines
- 2,278,055 extracted PK data lines
- 565,633 extracted ME data lines
- 3,748,769 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 19,261,787 FAERS (post-marketing) reports
- 17,825 documents / 363,680 pages of EMA Approval documents
- 20,649 documents / 792,965 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
The content release includes the following updates:
2 new drugs in PharmaPendium
- Bupropion Hydrochloride; Dextromethorphan Hydrobromide
- Spesolimab
FDA Approval Documents:
- 175 new FDA Approval Documents
- 1,982 new pages of FDA Approval Documents
The new totals for PharmaPendium are:
- 2,994,913 pages of FDA Approval documents (Including FDA Classic Collection)
- 143,050 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,825 drugs with data in PharmaPendium
- 2,347,271 extracted safety data lines
- 2,272,707 extracted PK data lines
- 562,753 extracted ME data lines
- 3,748,769 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 19,261,787 FAERS (post-marketing) reports
- 17,727 documents / 360,753 pages of EMA Approval documents
- 20,649 documents / 792,965 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
The content release includes the following updates:
7 new drugs in PharmaPendium
- Betula Pendula Roth; Betula Pubescens Ehrh.
- COVID-19 Vaccine (Valneva)
- Leuprorelin Mesilate
- Linzagolix Choline
- Mosunetuzumab
- Olipudase Alfa
- Sitagliptin Hydrochloride Monohydrate
FDA Approval Documents:
- 232 new FDA Approval Documents
- 3,856 new pages of FDA Approval Documents
EMA Documents:
- 175 new EMA documents
- 472 updated EMA documents
- 3,952 new pages of EMA Documents
Extracted PK data observations:
- 9,784 new extracted PK data lines
Extracted Safety data observations:
- 7,559 new extracted safety data lines
Metabolizing Enzymes Database:
- 5,746 new ME extracted data lines
Published Toxicity Database:
- 533 new safety records
Efficacy Database:
- 37,519 new extracted data lines
The new totals for PharmaPendium are:
- 2,992,931 pages of FDA Approval documents (Including FDA Classic Collection)
- 142,875 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,823 drugs with data in PharmaPendium
- 2,343,722 extracted safety data lines
- 2,272,723 extracted PK data lines
- 562,753 extracted ME data lines
- 3,748,769 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 19,261,787 FAERS (post-marketing) reports
- 17,727 documents / 360,753 pages of EMA Approval documents
- 20,649 documents / 792,965 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
The content release includes the following updates:
2 new drugs in PharmaPendium
- Levoketoconazole
- Venlafaxine Besylate Monohydrate
FDA Approval Documents:
- 371 new FDA Approval Documents
- 4,368 new pages of FDA Approval Documents
FDA Advisory Committee Documents:
- 178 new FDA Advisory Committee Documents
- 5,958 new pages of FDA Advisory Committee Documents
FAERS:
- 432,610 new FAERS reports (2022_Q2)
The new totals for PharmaPendium are:
- 2,989,075 pages of FDA Approval documents (Including FDA Classic Collection)
- 142,643 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,816 drugs with data in PharmaPendium
- 2,335,631 extracted safety data lines
- 2,262,939 extracted PK data lines
- 557,007 extracted ME data lines
- 3,711,250 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 19,261,732 FAERS (post-marketing) reports
- 17,552 documents / 356,801 pages of EMA Approval documents
- 20,649 documents / 792,965 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
The content release includes the following updates:
FDA Approval Documents:
- 669 new FDA Approval Documents
- 7,691 new pages of FDA Approval Documents
EMA Documents:
- 96 new EMA documents
- 2,027 new pages of EMA Documents
Extracted PK data observations:
- 5,500 new extracted PK data lines
Extracted Safety data observations:
- 4,299 new extracted safety data lines
Metabolizing Enzymes Database:
- 763 new ME extracted data lines
Published Toxicity Database:
- 457 new safety records
The new totals for PharmaPendium are:
- 2,984,707 pages of FDA Approval documents (Including FDA Classic Collection)
- 142,272 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,814 drugs with data in PharmaPendium
- 2,335,631 extracted safety data lines
- 2,262,939 extracted PK data lines
- 557,007 extracted ME data lines
- 3,711,250 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 18,829,122 FAERS (post-marketing) reports
- 17,552 documents / 356,801 pages of EMA Approval documents
- 20,471 documents / 787,007 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
The content release includes the following updates:
1 new drugs in PharmaPendium
- Vutrisiran
FDA Approval Documents:
- 417 new FDA Approval Documents
- 6,016 new pages of FDA Approval Documents
The new totals for PharmaPendium are:
- 2,977,016 pages of FDA Approval documents (Including FDA Classic Collection)
- 141,603 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,814 drugs with data in PharmaPendium
- 2,330,875 extracted safety data lines
- 2,257,439 extracted PK data lines
- 556,244 extracted ME data lines
- 3,711,250 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 18,829,122 FAERS (post-marketing) reports
- 17,456 documents / 354,774 pages of EMA Approval documents
- 20,471 documents / 787,007 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
The content release includes the following updates:
FDA Approval Documents:
- 703 new FDA Approval Documents
- 7,391 new pages of FDA Approval Documents
EMA Documents:
- 86 new EMA documents
- 639 updated EMA documents
- 2,416 new pages of EMA Documents
Extracted PK data observations:
- 20,954 new extracted PK data lines
Extracted Safety data observations:
- 8,116 new extracted safety data lines
Metabolizing Enzymes Database:
- 3,810 new ME extracted data lines
Published Toxicity Database:
- 754 new safety records
Efficacy Database:
- 31,206 new extracted data lines
The new totals for PharmaPendium are:
- 2,971,000 pages of FDA Approval documents (Including FDA Classic Collection)
- 141,186 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,813 drugs with data in PharmaPendium
- 2,331,161 extracted safety data lines
- 2,257,497 extracted PK data lines
- 556,144 extracted ME data lines
- 3,711,276 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 18,829,122 FAERS (post-marketing) reports
- 17,458 documents / 354,874 pages of EMA Approval documents
- 20,471 documents / 787,007 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
The content release includes the following updates:
8 new drugs in PharmaPendium
- Amoxicillin; Clarithromycin; Vonoprazan
- Amoxicillin; Vonoprazan
- Lisocabtagene Maraleucel
- Mavacamten
- Oteseconazole
- Tapinarof
- Tirzepatide
- Tixagevimab; Cilgavimab
FDA Approval Documents:
- 879 new FDA Approval Documents
- 11,068 new pages of FDA Approval Documents
FDA Advisory Committee Documents:
- 76 new FDA Advisory Committee Documents
- 2,324 new pages of FDA Advisory Committee Documents
EMA Documents:
- 111 new EMA documents
- 3,190 new pages of EMA Documents
New Meyler’s Documents and Safety data observations:
- 1,436 New Meyler’s documents
- 6,295 pages of New Meyler’s Documents
- 105,517 New Meyler’s extracted safety data lines
Extracted PK data observations:
- 2,863 new extracted PK data lines
Extracted Safety data observations:
- 4,537 new extracted safety data lines
Metabolizing Enzymes Database:
- 1,151 new ME extracted data lines
Published Toxicity Database:
- 726 new safety records
The new totals for PharmaPendium are:
- 2,963,609 pages of FDA Approval documents (Including FDA Classic Collection)
- 140,483 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,813 drugs with data in PharmaPendium
- 2,354,793 extracted safety data lines
- 2,236,543 extracted PK data lines
- 552,334 extracted ME data lines
- 3,680,070 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 18,829,122 FAERS (post-marketing) reports
- 17,372 documents / 352,458 pages of EMA Approval documents
- 20,471 documents / 787,007 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
The content release includes the following updates:
FDA Approval Documents:
- 420 new FDA Approval Documents
- 6,115 new pages of FDA Approval Documents
FAERS:
- 457,110 new FAERS reports (2022_Q1)
The new totals for PharmaPendium are:
- 2,952,541 pages of FDA Approval documents (Including FDA Classic Collection)
- 139,604 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,805 drugs with data in PharmaPendium
- 2,317,045 extracted safety data lines
- 2,233,680 extracted PK data lines
- 551,183 extracted ME data lines
- 3,681,160 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 18,828,706 FAERS (post-marketing) reports
- 17,261 documents / 349,268 pages of EMA Approval documents
- 20,395 documents / 784,683 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
The content release includes the following updates:
2 new drugs in PharmaPendium
- Ciltacabtagene Autoleucel
- Somatrogon
FDA Approval Documents:
- 294 new FDA Approval Documents
- 4,669 new pages of FDA Approval Documents
EMA Documents:
- 93 new EMA documents
- 818 updated EMA documents
- 2,280 new pages of EMA Documents
Extracted PK data observations:
- 7,166 new extracted PK data lines
Extracted Safety data observations:
- 11,903 new extracted safety data lines
Metabolizing Enzymes Database:
- 2,713 new ME extracted data lines
Published Toxicity Database:
- 620 new safety records
Efficacy Database:
- 37,371 new extracted data lines
The new totals for PharmaPendium are:
- 2,946,426 pages of FDA Approval documents (Including FDA Classic Collection)
- 139,184 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,805 drugs with data in PharmaPendium
- 2,317,045 extracted safety data lines
- 2,233,680 extracted PK data lines
- 551,183 extracted ME data lines
- 3,681,160 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 18,371,596 FAERS (post-marketing) reports
- 17,261 documents / 349,268 pages of EMA Approval documents
- 20,395 documents / 784,683 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
The content release includes the following updates:
5 new drugs in PharmaPendium
- Dextroamphetamine
- Ganaxolone
- Lutetium (177Lu) Vipivotide Tetraxetan
- Nivolumab; Relatlimab
- Pacritinib Citrate
FDA Approval Documents:
- 142 new FDA Approval Documents
- 2,416 new pages of FDA Approval Documents
FDA Advisory Committee Documents:
- 51 new FDA Advisory Committee Documents
- 1,838 new pages of FDA Advisory Committee Documents
The new totals for PharmaPendium are:
- 2,941,757 pages of FDA Approval documents (Including FDA Classic Collection)
- 138,890 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,803 drugs with data in PharmaPendium
- 2,304,522 extracted safety data lines
- 2,226,514 extracted PK data lines
- 548,470 extracted ME data lines
- 3,643,789 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 18,370,019 FAERS (post-marketing) reports
- 17,168 documents / 346,988 pages of EMA Approval documents
- 20,395 documents / 784,683 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
The content release includes the following updates:
FDA Approval Documents:
- 223 new FDA Approval Documents
- 3,776 new pages of FDA Approval Documents
EMA Documents:
- 85 new EMA documents
- 2,372 new pages of EMA Documents
Extracted PK data observations:
- 6,218 new extracted PK data lines
Extracted Safety data observations:
- 3,763 new extracted safety data lines
Metabolizing Enzymes Database:
- 2,306 new ME extracted data lines
Published Toxicity Database:
- 265 new safety records
The new totals for PharmaPendium are:
- 2,939,341 pages of FDA Approval documents (Including FDA Classic Collection)
- 138,748 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,798 drugs with data in PharmaPendium
- 2,304,522 extracted safety data lines
- 2,226,514 extracted PK data lines
- 548,470 extracted ME data lines
- 3,643,789 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 18,370,019 FAERS (post-marketing) reports
- 17,168 documents / 346,988 pages of EMA Approval documents
- 20,344 documents / 782,845 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
The content release includes the following updates:
3 new drugs in PharmaPendium
- Etafilcon A Lens with Ketotifen
- Mitapivat Sulfate
- Sutimlimab
FDA Approval Documents:
- 263 new FDA Approval Documents
- 3,756 new pages of FDA Approval Documents
FAERS:
- 407,596 new FAERS reports (2021_Q4).
The new totals for PharmaPendium are:
- 2,935,565 pages of FDA Approval documents (Including FDA Classic Collection)
- 138,525 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,798 drugs with data in PharmaPendium
- 2,300,494 extracted safety data lines
- 2,220,296 extracted PK data lines
- 546,164 extracted ME data lines
- 3,643,789 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 18,370,019 FAERS (post-marketing) reports
- 17,083 documents / 344,616 pages of EMA Approval documents
- 20,344 documents / 782,845 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
The content release includes the following updates:
3 new drugs in PharmaPendium
- Asciminib hydrochloride
- Avacopan
- Celecoxib; Tramadol Hydrochloride
FDA Approval Documents:
- 341 new FDA Approval Documents
- 4,450 new pages of FDA Approval Documents
Extracted Safety data observations:
- 47,534 new extracted safety data lines
Published Toxicity Database:
- 715 new safety records
FAERS:
- 502,296 new FAERS reports (2021_Q3)
The new totals for PharmaPendium are:
- 2,907,307 pages of FDA Approval documents (Including FDA Classic Collection)
- 136,511 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,775 drugs with data in PharmaPendium
- 2,267,359 extracted safety data lines
- 2,195,372 extracted PK data lines
- 532,932 extracted ME data lines
- 3,576,684 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 17,962,359 FAERS (post-marketing) reports
- 16,686 documents / 332,496 pages of EMA Approval documents
- 20,152 documents / 776,605 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
The content release includes the following updates:
1 new drug in PharmaPendium
- Regdanvimab
FDA Approval Documents:
- 225 new FDA Approval Documents
- 2,784 new pages of FDA Approval Documents
EMA Documents:
- 110 new EMA documents
- 671 updated EMA documents
- 2,593 new pages of EMA Documents
Extracted PK data observations:
- 6,766 new extracted PK data lines
Extracted Safety data observations:
- 9,193 new extracted safety data lines
Metabolizing Enzymes Database:
- 2,856 new ME extracted data lines
Published Toxicity Database:
- 642 new safety records
Efficacy Database:
- 38,189 new extracted data lines
The new totals for PharmaPendium are:
- 2,916,139 pages of FDA Approval documents (Including FDA Classic Collection)
- 137,152 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,779 drugs with data in PharmaPendium
- 2,282,531 extracted safety data lines
- 2,207,668 extracted PK data lines
- 539,815 extracted ME data lines
- 3,614,873 extracted Efficacy data lines
- 184,226 extracted Activity data lines
- 17,962,371 FAERS (post-marketing) reports
- 16,852 documents / 336,247 pages of EMA Approval documents
- 20,281 documents / 779,208 pages of FDA Advisory Committees Meetings documents
- 10,906 documents / 308,149 pages of FDA Classic Collection
- 2,769 documents / 32,290 pages of DESI documents
Did we answer your question?
Related answers
Recently viewed answers
Functionality disabled due to your cookie preferences